Take

Why is Take Ltd falling/rising?

As of 31-Aug, Take Ltd's stock price is at 15.47, reflecting a 4.98% decrease and a total decline of 34.7% over the last 11 days. The stock is underperforming against moving averages and has seen reduced investor interest, contributing to its bearish trend.

As of 31-Aug, Take Ltd's stock price is falling, currently at 15.47, which reflects a decrease of 0.81 or 4.98%. The stock has been on a downward trend, having lost value for the last 11 consecutive days, resulting in a total decline of 34.7% during this period. This consistent drop is further evidenced by the stock's performance over different time frames, showing a significant year-to-date decline of 61.09%, compared to a modest 9.70% drop in the benchmark Sensex.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Investor participation has also decreased, with delivery volume on August 28 falling by 67.12% compared to the 5-day average, suggesting reduced interest from investors. Overall, these factors contribute to the ongoing decline in Take Ltd's stock price.

Who are in the management team of Take?

The management team of Take includes H R Srinivasan (Non Executive Director), Shobana N S (Executive Director), P Srinivasan (Company Secretary & Compliance Officer), Chella Gowrishankar (Director), and four Independent Directors: Chandrasekaran Nagarajan, Rangasami Seshadri, Kiran Sharma, and Ramesh Gopal. They oversee the company's operations and governance.

The management team of Take includes the following individuals:<BR><BR>1. H R Srinivasan - Non Executive Director<BR>2. Shobana N S - Executive Director<BR>3. P Srinivasan - Company Secretary & Compliance Officer<BR>4. CHELLA GOWRISHANKAR - Director<BR>5. CHANDRASEKARAN NAGARAJAN - Independent Director<BR>6. Rangasami Seshadri - Independent Director<BR>7. Kiran Sharma - Independent Director<BR>8. RAMESH GOPAL - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and governance. If you need more specific information about their roles or contributions, feel free to ask!

What does Take do?

Take Ltd is a micro-cap healthcare services company focused on Life Sciences, Software, and IT solutions, with recent net sales of 30 Cr and a net profit of 1 Cr as of June 2026. It has a market cap of INR 229 Cr and key metrics include a P/E ratio of 39.00 and a return on equity of 13.74%.

Overview:<BR>Take Ltd is a micro-cap company in the healthcare services industry, specializing in domain-intensive services and solutions in Life Sciences, Software, and Information Technology.<BR><BR>History:<BR>Take Ltd was incorporated on December 20, 2000. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 30 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 229 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 39.00 <BR>Industry P/E: 22 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.01 <BR>Return on Equity: 13.74% <BR>Price to Book: 7.77 <BR><BR>Contact Details:<BR>Address: No 27 Tank Bund Road, Nungambakkam Chennai Tamil Nadu : 600034 <BR>Tel: 91-044-24617358/24617359 <BR>Email: secretarial@takesolutions.com <BR>Website: http://www.takesolutions.com

Who are the peers of the Take?

Take's peers include Hemant Surgical, Prevest Denpro, Nureca, Bilcare, Jeevan Scienti., Star Imaging, and QMS Medical. Take has Below Average management risk and a 1-year return of 50.49%, while Nureca leads with a 41.92% return and Prevest Denpro has the lowest at -32.25%.

Peers: The peers of Take are Hemant Surgical, Prevest Denpro, Nureca, Bilcare, Jeevan Scienti., Star Imaging, and QMS Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Prevest Denpro and Star Imaging, while Average management risk is found at Hemant Surgical and QMS Medical. Below Average management risk is present at Take, Nureca, Bilcare, Jeevan Scienti. and the rest. Growth is rated as Good for Hemant Surgical and Bilcare, Below Average for Prevest Denpro, Nureca, Take, Jeevan Scienti., and Star Imaging, while the rest have Below Average growth. Capital Structure is rated as Excellent for Prevest Denpro, Good for Hemant Surgical and Nureca, and Below Average for Take, Bilcare, Jeevan Scienti., Star Imaging, and QMS Medical.<BR><BR>Return Snapshot: Nureca has the highest 1-year return at 41.92%, while Prevest Denpro has the lowest at -32.25%. Take's 1-year return of 50.49% is significantly higher than that of Prevest Denpro. Additionally, the six-month return is negative for Prevest Denpro, Take, and QMS Medical.

How big is Take?

As of 31st August, Take Ltd has a market capitalization of 229.00 Cr, with recent net sales of 84.56 Cr and a net profit of 12.82 Cr. Shareholder's funds are 20.53 Cr, and total assets amount to 36.48 Cr.

As of 31st August, Take Ltd has a market capitalization of 229.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Take Ltd reported Net Sales of 84.56 Cr and a Net Profit of 12.82 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 20.53 Cr and Total Assets of 36.48 Cr.

Which are the latest news on Take?

Should I buy, sell or hold Take Solutions Ltd?

When is the next results date for Take Solutions Ltd?

The next results date for Take Solutions Ltd is 11 August 2026.

The next results date for Take Solutions Ltd is scheduled for 11 August 2026.

Are Take Solutions Ltd latest results good or bad?

Take Solutions Ltd's latest results show a return to revenue with net sales of ₹54.19 crores and a net profit of ₹4.36 crores, but the company faces significant concerns due to negative operating margins, reliance on non-operating income, and the complete exit of promoters, indicating an unfavorable overall assessment.

Take Solutions Ltd's latest results for Q4 FY26 present a mixed picture that leans towards concern. On one hand, the company reported net sales of ₹54.19 crores, marking its first revenue after several quarters of zero sales, which is a positive sign of some operational activity resuming. Additionally, the consolidated net profit of ₹4.36 crores reflects a significant increase of 292.79% quarter-over-quarter, which might seem encouraging at first glance.<BR><BR>However, a deeper analysis reveals troubling underlying issues. The operating margin, excluding other income, was deeply negative at -1.51%, indicating that the core business remains unprofitable despite the revenue generation. The reported profit was heavily reliant on other income, which accounted for 118.81% of the profit before tax, raising serious questions about the sustainability and quality of the earnings.<BR><BR>Moreover, the complete exit of promoters from the company signals a lack of confidence in its recovery prospects. The company's financial health has deteriorated significantly over the years, with shareholder funds collapsing from ₹1,124.69 crores in March 2021 to just ₹20.53 crores in March 2025. <BR><BR>In summary, while the return to revenue generation is a positive development, the ongoing operational losses, reliance on non-operating income for profitability, and the complete promoter exit suggest that the results are more indicative of a speculative situation rather than a solid recovery. Therefore, the overall assessment of Take Solutions Ltd's latest results leans towards being unfavorable.

How has been the historical performance of Take Solutions?

Take Solutions has experienced a significant decline in financial performance, with net sales dropping from 2,212.90 crore in March 2020 to 0.00 crore in March 2025, although it reported a net profit of 37.47 crore in March 2025 after years of losses. Total assets also fell sharply from 2,464.45 crore to 36.48 crore during the same period.

Answer:<BR>The historical performance of Take Solutions shows a significant decline in net sales and profitability over the years, culminating in a net profit of 37.47 crore in March 2025 after several years of losses.<BR><BR>Breakdown:<BR>Take Solutions experienced a drastic drop in net sales from 2,212.90 crore in March 2020 to 0.00 crore in March 2025. The total operating income followed a similar trend, decreasing from 2,212.90 crore in March 2020 to 0.00 crore in March 2025. Operating profit (PBDIT) also fell sharply, moving from a profit of 195.29 crore in March 2020 to a loss of 7.47 crore in March 2025. The company reported a profit before tax of 0.74 crore in March 2025, a recovery from the previous years of losses, while profit after tax also showed a positive shift to 0.74 crore. The total assets decreased significantly from 2,464.45 crore in March 2020 to 36.48 crore in March 2025, reflecting a severe contraction in the company's financial position. Despite these challenges, the company managed to achieve a net cash inflow of 2.00 crore in March 2025, contrasting with the negative cash flows seen in prior years.

Who are the top shareholders of the Take Solutions?

The top shareholders of Take Solutions are Take Solutions Pte Limited, which holds 52.9% of the shares, and individual investors who collectively own 40.45%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of Take Solutions include the promoters, with Take Solutions Pte Limited holding the largest share at 52.9%. Additionally, individual investors collectively hold 40.45% of the company's shares. There are no mutual funds or foreign institutional investors (FIIs) currently holding shares in the company.

Is Take Solutions overvalued or undervalued?

As of May 31, 2024, Take Solutions is considered risky and overvalued due to a high PE ratio of 128.70, negative EV to EBIT of -16.66, and a troubling ROCE of -43.98%, especially when compared to peers like TCS and Infosys, while also underperforming the Sensex with a year-to-date return of -45.88%.

As of 31 May 2024, the valuation grade for Take Solutions has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently deemed overvalued, particularly when considering its high PE ratio of 128.70 and a negative EV to EBIT of -16.66. Additionally, the return on capital employed (ROCE) stands at a concerning -43.98%, which further underscores the company's financial struggles.<BR><BR>When compared to peers, Take Solutions' valuation metrics are starkly unfavorable. For instance, TCS, which is rated attractive, has a PE ratio of 25.23, while Infosys, rated fair, has a PE of 24.32. The PEG ratio for Take Solutions is 1.26, which, while not excessively high, is still indicative of overvaluation relative to its peers. The company's recent stock performance has also lagged behind the Sensex, with a year-to-date return of -45.88% compared to the Sensex's 5.59%, reinforcing the perception of overvaluation in the current market context.

What is the technical trend for Take Solutions?

As of May 14, 2025, Take Solutions shows a mildly bearish trend overall, with mixed signals from MACD and bearish moving averages, despite a mildly bullish weekly MACD.

As of 14 May 2025, the technical trend for Take Solutions has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The moving averages on a daily basis are mildly bearish, and the Bollinger Bands show a bearish trend in both weekly and monthly time frames. The KST is mildly bullish weekly but bearish monthly, and Dow Theory reflects a mildly bearish position on the weekly chart with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the mixed signals from MACD and the bearish moving averages.

Has Take Solutions declared dividend?

Take Solutions Ltd has declared a 40% dividend, amounting to 0.4 per share, but the dividend yield is 0%. The company has experienced significant losses over various periods, with total returns ranging from -49.6% to -86.45%.

Take Solutions Ltd has declared a 40% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 40%<BR>- Amount per share: 0.4<BR>- Ex-date: 01 Aug 19<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -49.6%, the dividend return was 0%, resulting in a total return of -49.6%.<BR><BR>Over the past year, the price return was -55.81%, the dividend return was 0%, leading to a total return of -55.81%.<BR><BR>For the 2-year period, the price return was -50.72%, the dividend return was 0%, culminating in a total return of -50.72%.<BR><BR>In the 3-year span, the price return was -62.62%, the dividend return was 0%, which resulted in a total return of -62.62%.<BR><BR>Over the last 4 years, the price return was -86.45%, the dividend return was 0%, leading to a total return of -86.45%.<BR><BR>Finally, in the 5-year period, the price return was -85.18%, the dividend return was 0%, resulting in a total return of -85.18%.<BR><BR>Overall, while Take Solutions Ltd has declared a dividend, the company has not provided any dividend yield, and the total returns across all periods indicate significant losses, suggesting a challenging financial performance.